The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Smart start: Final results of rituximab, lenalidomide, and ibrutinib lead in prior to combination with chemotherapy for patients with newly diagnosed diffuse large B-cell lymphoma.
Jason Westin
Consulting or Advisory Role - Celgene; Genentech/Abbvie; Kite, a Gilead company; Kite/Gilead; Novartis; ProNAi; Spectrum Pharmaceuticals
Research Funding - Bristol-Myers Squibb; Celgene; Genentech; Janssen; Karyopharm Therapeutics; Kite/Gilead; Novartis; ProNAi
Loretta J. Nastoupil
Honoraria - Bayer; Celgene; Gilead Sciences; Janssen Oncology; Novartis; Spectrum Pharmaceuticals
Research Funding - Celgene; Genentech/Roche; Janssen Biotech; Karus Therapeutics; LAM Therapeutics; TG Therapeutics
Luis Fayad
No Relationships to Disclose
Fredrick B. Hagemeister
No Relationships to Disclose
Yasuhiro Oki
Employment - Jazz Pharmaceuticals
Honoraria - Takeda
Consulting or Advisory Role - Bristol-Myers Squibb; Meiji Seika Kaisha
Francesco Turturro
No Relationships to Disclose
Sairah Ahmed
No Relationships to Disclose
Maria Alma Rodriguez
Research Funding - Amgen (Inst); GlaxoSmithKline (Inst); Ortho Biotech (Inst); Pfizer (Inst)
Hun Ju Lee
No Relationships to Disclose
Raphael Steiner
No Relationships to Disclose
Ranjit Nair
No Relationships to Disclose
Simrit Parmar
No Relationships to Disclose
Ken H Young
No Relationships to Disclose
Timothy McDonnell
No Relationships to Disclose
Hubert Chuang
No Relationships to Disclose
Michael Richard Green
Research Funding - Genzada Pharmaceuticals
Travel, Accommodations, Expenses - Abbvie
Sattva Swarup Neelapu
Honoraria - Bio Ascend; Dava Oncology; Medscape; Physicans' Education Resource
Consulting or Advisory Role - Celgene; Cell Medica; Gilead Sciences; Incyte; Kite, a Gilead company; Merck Sharp & Dohme; Novartis; Pfizer; Precision Biosciences; Unum Therapeutics
Research Funding - Acerta Pharma; Bristol-Myers Squibb; Celgene; Cellectis; Gilead Sciences; Karus Therapeutics; Kite, a Gilead company; Merck Sharp & Dohme; Pharmacyclics; poseida therapeutics; Unum Therapeutics
Travel, Accommodations, Expenses - Celgene; Chugai Pharma; Dava Oncology; Kite/Gilead; Medscape; Merck; Novartis; Pfizer; Physicans' Education Resource; Precision Biosciences; Unum Therapeutics
Richard Eric Davis
Research Funding - Karus Therapeutics (Inst)